Article
Investigation of epistasis between DAOA and 5HTR1A variants on clinical outcomes in patients with schizophrenia.
Genetic testing and molecular biomarkers - 1 Jun 2013
Chiesa Alberto, Lia Loredana, Han Changsu, Lee Soo-Jung, Pae Chi-Un, Serretti Alessandro
Abstract excerpt
PURPOSE: In two recent studies of our group, rs10042486, a single-nucleotide polymorphism (SNP) within 5HTR1A, and rs7139958, a SNP within the d-amino acid oxidase activator (DAOA) were found to be associated with clinical improvement, as detected by the positive symptom subscale of the Positive and Negative Symptoms Scale (PANSS) in a sample 221 Korean schizophrenia patients treated with various antipsychotics....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
